ICD 10 CM E13.3522 | Description & Clinical Information

ICD 10 E13.3522 describes a specific medical condition characterized by insufficient production or utilization of insulin, resulting in high levels of blood glucose, and the presence of proliferative diabetic retinopathy (PDR) with traction retinal detachment (TRD) involving the macula of the left eye, which is a condition where the retina is pulled away from the retinal pigment epithelium, and this code is used when the provider identifies a type of DM with PDR and TRD involving the macula of the left eye that is not represented by another code.

Official Description Of E13.3522

The ICD 10 CM book defines ICD 10 code E13.3522 as:

Clinical Information

The diagnosis describes by the ICD-10-CM E13.3522 code is proliferative diabetic retinopathy (PDR), a condition that affects the microvessels of the retina, leading to blockage and inadequate oxygen supply to the tissue. This lack of oxygen leads to the formation of new, weak vessels designed to compensate for the loss of oxygen. These vessels are prone to breaking and bleeding, which can cause vitreous hemorrhage, also known as bleeding in the eye.

Individuals with other specified diabetes mellitus (DM) who develop PDR and TRD involving the macula of the left eye may experience various symptoms, such as eye pain, blurred vision, double vision, retinal detachment, headache, cataract, glaucoma, dizziness, and in severe cases, blindness. Moreover, general symptoms of DM include increased urinary frequency and thirst, extreme hunger, fatigue, weight loss, and frequent infections. Other symptoms may vary depending on the type and nature of the disease, such as weakness, pain, difficulty breathing, loss of appetite, anemia, high blood pressure, and night sweats.

To diagnose this condition, healthcare providers will typically perform a physical and ophthalmic examination, review the patient’s medical history, and assess the signs and symptoms presented. Additionally, various laboratory tests, including blood tests to measure fasting plasma glucose and levels of HbA1c, lipid profile, and urine and stool examination, may be necessary. Imaging tests, such as plain X-ray and ultrasound of the abdomen to detect any anomalies in the pancreas, are also common. Other diagnostic procedures will focus on examining the eyes themselves, including fluorescein angiography, optical coherence tomography (OCT), and color fundus.

Given the severity of the condition, early identification and treatment are crucial. Treatment depends on the type of diabetes present but should involve metabolic and blood pressure control for optimal eye care. Photocoagulation, which utilizes laser treatment, may be performed on either the macular or pan-retinal regions of the eye to prevent retinal bleeding. Other treatments may include antiVEGF medications and steroids to reduce inflammation, edema, and vascular growth. In more severe cases, eye surgery may be necessary, such as vitrectomy, which involves the surgical removal of some or all of the vitreous humor from the eye, to reduce pressure or to correct nerve damage.

Finally, it is important to note that DM can be treated with insulin and non-insulin-based therapies, depending on the type of diabetes present and the patient’s glucose levels. Effective diabetes management, together with optimal eye care, can help prevent the development of PDR, TRD, and other complications associated with diabetes.